Back to top

Image: Bigstock

5 Stocks with High ROE to Buy as Earnings Bells Chime

Read MoreHide Full Article

The U.S. equity market is presently hovering around record high territory buoyed by better-than-expected performance of companies that have reported so far. This has lured investors back to the equity markets from safe-haven assets like government bond and gold.

As investors scout for cherry pickings, they are often on the lookout for ‘cash cow’ stocks that would enable them to milk more cash or profits.

However, singling out cash-rich stocks alone does not make them a solid investment proposition unless they are backed by attractive efficiency ratios like return on equity (ROE). A high ROE ensures that the company is reinvesting its cash at a high rate of return.

ROE:  A Key Financial Metric

ROE = Net Income/Shareholders’ Equity

ROE helps investors distinguish between profit-generating companies from profit burners and is a useful tool for determining the financial health of a company. In other words, this financial metric enables investors to identify those stocks that diligently deploy cash for higher investor returns instead of piling up the dry powder.

Moreover, ROE is often used to compare the profitability of a company with other firms in the industry – the higher the better. It measures how well a company is growing its profits without investing any new equity capital in the business and portrays management efficiency in rewarding shareholders with attractive risk-adjusted returns.

Parameters Used for Screening

In order to shortlist stocks that are cash rich with high ROE, we added Cash Flow greater than $1 billion and ROE greater than X-Industry as our primary screening parameters. However, these are not the ultimate criteria for short listing stocks. As such, we have added a few additional criteria to arrive at a winning strategy.   

Price/Cash Flow less than X-Industry: This metric measures how much investors pay for one dollar of free cash flow. A lower ratio indicates that investors need to pay less for a better cash flow generating stock.

Return on Assets (ROA) greater than X-Industry: This metric determines how much profit a company earns for every dollar of its assets, which include cash, accounts receivable, property, equipment, inventory and furniture. Of course, the higher the ROA, the better it is.

5 Year EPS Historical Growth greater than X-Industry: This criterion indicates that continued earnings momentum has translated to solid cash strength.   

Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or #2 (Buy) stocks are known to outperform irrespective of the market environment.

Here are five of the 17 stocks that qualified the screening:

Altria Group, Inc. (MO - Free Report) : Headquartered in Richmond, VA, Altria manufactures and sells cigarettes, smokeless products, and wine through its subsidiaries. This Zacks Rank #2 (Buy) stock has a healthy long-term earnings growth expectation of 7.4%.

The Priceline Group Inc. : Norwalk, CT-based Priceline is one of the largest online travel companies in the world. The company’s travel-related offerings cover hotel rooms, airline tickets, rental cars, vacation packages and cruises. This Zacks Rank #2 stock has a healthy long-term earnings growth expectation of 18.1% and a trailing four-quarter average earnings surprise of 4.7%.

Zoetis Inc. (ZTS - Free Report) : Founded in 1952 and headquartered in Florham Park, NJ, Zoetis manufactures and markets veterinary vaccines, medicines, diagnostic products and related services for livestock and companion animals across the globe. This Zacks Rank #2 stock has a solid long-term earnings growth expectation of 12.6% and a trailing four-quarter average earnings surprise of 16.4%.

Gilead Sciences Inc. (GILD - Free Report) : Headquartered in Foster City, CA, Gilead Sciences is a biopharmaceutical company, focused on developing drugs for the treatment of human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, cardiovascular, hematology/oncology and inflammation/respiratory diseases. This Zacks Rank #2 stock has a trailing four-quarter average earnings surprise of 6.4%.

Citrix Systems, Inc. : Headquartered in Fort Lauderdale, FL, Citrix offers an integrated portfolio of Workspace-as-a-Service, application delivery, virtualization, mobility, network delivery and file sharing solutions. This Zacks Rank #2 stock has a solid long-term earnings growth expectation of 12.2% and a trailing four-quarter average earnings surprise of 36.6%.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.  

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

 Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.

Zacks Restaurant Recommendations: Inaddition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Gilead Sciences, Inc. (GILD) - free report >>

Altria Group, Inc. (MO) - free report >>

Zoetis Inc. (ZTS) - free report >>

Published in